NL-OMON28418
Recruiting
Not Applicable
Advanced neuroimaging, biomarkers, clinical and cognitive functioning in early MS
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Bristol Myers Squibb
- Enrollment
- 180
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Ability to understand the purpose and risks of the study and provide signed and dated informed consent and authorization to use protected health information (PHI) in accordance with national and local subject privacy regulations;
- •2\. All participants should be 18\-65 years of age;
- •3\. Sufficient Dutch proficiency to be able to comprehend and to perform the neuropsychological examination;
- •4\. All participants need to meet the safety criteria to undergo an MRI examination;
- •For the patients specifically:
- •5\. Only patients that are recently (up to 12 months) diagnosed with clinically definite MS according to the 2017 revision of the McDonald MS criteria will be included;
- •6\. Only patients with (active) relapsing\-remitting disease course will be included;
- •7\. All types of disease modifying treatment for MS are allowed.
Exclusion Criteria
- •1\. Unable or unwilling to provide informed consent;
- •2\. Presence or history of alcohol or drug abuse;
- •3\. Presence or history of psychiatric or neurological disease of the CNS (for patients: neurological disease other than MS) that is expected to affect any of the outcome measures (will be discussed with the principal investigator and neurologist);
- •4\. Presence of contra\-indications for MRI;
- •5\. Participation in other (scientific) studies using cognitive or physical training programs (interventions other than standard care) at baseline to avoid noise.
- •For the patient groups specifically:
- •6\. Patients with disease categorized as clinically isolated syndrome, primary progressive, secondary progressive or progressive relapsing;
- •7\. Relapses or steroid treatment less than four weeks prior to the visits. Visits of included patients experiencing a relapse will be postponed if possible;
- •8\. Patients undergoing a cognitive relapse. Visits of included patients experiencing a cognitive relapse will be postponed if possible.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Investigation of New Imaging Biomarkers for Brain Tumors Using Advanced MRI Techniquesbrain tumors and brain tumor-like diseasesJPRN-jRCT1030220319Aoki Shigeki1,000
Recruiting
Not Applicable
To explore the neuroimaging mechanism and clinical effect of acupuncture and LF-rTMS on patients after strokestrokeITMCTR2100004773Shenzhen Nanshan People's Hospital
Recruiting
Not Applicable
Advanced MRI techniques and biomarkers to substitute gadolinium enhanced MRI for the detection of disease activity in multiple sclerosis.Multiple Sclerosis10007951NL-OMON53657Amsterdam UMC75
Not yet recruiting
Not Applicable
Brain science of chronic pain using PET and MRIfibromyalgia, chronic low back pain, postherpetic neuralgia, other chronic pain disordersJPRN-UMIN000040403The Jikei University School of Medicine80
Terminated
Not Applicable
Neuroimaging & Plasma Markers for Predicting Outcomes After Mild Traumatic Brain InjuryTraumatic Brain InjuryInjury of Body RegionNCT02891941Johns Hopkins University10